Replies to post #132 on Janex International INC. (JANX)

[TheFinalCD]

$JANX in metastatic castration-resistant prostate cancer
High PSA response rates: 100% achieved best PSA50 declines
Deep PSA declines: 63% achieved best PSA90 declines; 31% achieved best PSA99 declines
Durable PSA response at ≥ 12 weeks: 75% maintained PSA50 declines; 50%…

— Pharmdca (@Pharmdca) December 2, 2024